熱門資訊> 正文

Crystem Pharmaceuticals任命Tobin Schilke为首席财务官

2025-02-24 21:57

Crinetics Pharmaceuticals (NASDAQ:CRNX) on Monday announced the appointment of Tobin Schilke as chief financial officer (CFO), effective February 28, 2025.
Prior to joining Crinetics, Schilke served as CFO at Revance Therapeutics. Previously, Schilke served as CFO at Achaogen.
The company expects to grant Schilke 52,000 restricted stock units (RSUs) and a stock option to purchase 80,000 shares of common stock.
CRNX +1.44% premarket to $38.
Source: Press Release

More on Crinetics Pharmaceuticals

Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness
Crinetics upgraded to buy by Jefferies, atumelnant potential cited
Crinetics falls after mid-stage trial data adrenal disorder therapy
Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals
Historical earnings data for Crinetics Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。